These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19755823)

  • 1. [A case of inflammatory carcinoma, well-controlled by chemotherapy, especially, vinorelbine, S-1 and trastuzumab].
    Tanigawa T; Miyamoto Y; Abe M; Hasuo T; Doiguchi M; Sakamoto F
    Gan To Kagaku Ryoho; 2009 Sep; 36(9):1515-8. PubMed ID: 19755823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorouracil, epirubicin, and cyclophosphamide with either docetaxel or vinorelbine, with or without trastuzumab, as adjuvant treatments of breast cancer: final results of the FinHer Trial.
    Joensuu H; Bono P; Kataja V; Alanko T; Kokko R; Asola R; Utriainen T; Turpeenniemi-Hujanen T; Jyrkkiö S; Möykkynen K; Helle L; Ingalsuo S; Pajunen M; Huusko M; Salminen T; Auvinen P; Leinonen H; Leinonen M; Isola J; Kellokumpu-Lehtinen PL
    J Clin Oncol; 2009 Dec; 27(34):5685-92. PubMed ID: 19884557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of recurrent breast cancer responding to vinorelbine/trastuzumab combination therapy].
    Fujisawa M; Uomori T; Takehara K; Mitsugi Y; Yoshino K; Okumura M; Machida M; Kitabatake T; Ishibiki Y; Kojima K; Ogura K; Matsumoto T
    Gan To Kagaku Ryoho; 2009 Dec; 36(13):2631-5. PubMed ID: 20009469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A long-term survival case of local recurrence of breast cancer treated with combined modality therapy].
    Katsuta E; Ohkubo T; Someno Y; Saguchi M; Aoyagi H; Takahata T; Hasegawa K; Hamada S; Kaneko J; Maejima S
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2760-2. PubMed ID: 21224704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of liver metastases of breast cancer successfully treated by combination chemotherapy using hepatic arterial infusion of docetaxel and systemic administration of trastuzumab].
    Hashimoto K; Nio Y; Koike M; Itakura M; Yano S; Higami T
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1391-3. PubMed ID: 15446563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of multi-drug resistant recurrent breast cancer with multiple bone metastasis responding to TS-1 and trastuzumab].
    Nakajima H; Mizuta N; Mizuta M; Nakatsukasa K; Kobayashi A; Hachimine Y; Sakaguchi K; Fujiwara I; Sawai K
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1305-8. PubMed ID: 16969030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of neoadjuvant docetaxel, vinorelbine, and trastuzumab followed by surgery and adjuvant doxorubicin plus cyclophosphamide in women with human epidermal growth factor receptor 2-overexpressing locally advanced breast cancer.
    Limentani SA; Brufsky AM; Erban JK; Jahanzeb M; Lewis D
    J Clin Oncol; 2007 Apr; 25(10):1232-8. PubMed ID: 17296975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial.
    von Minckwitz G; Kümmel S; Vogel P; Hanusch C; Eidtmann H; Hilfrich J; Gerber B; Huober J; Costa SD; Jackisch C; Loibl S; Mehta K; Kaufmann M;
    J Natl Cancer Inst; 2008 Apr; 100(8):542-51. PubMed ID: 18398097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Two cases treated with trastuzumab as primary chemotherapy].
    Murakami K; Sakata H; Miyazawa Y; Matsushita K; Akutsu Y; Nishimori T; Yoneyama Y; Usui A; Kano M; Matsubara H; Ochiai T
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1683-7. PubMed ID: 17940391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A pilot study of trastuzumab and vinorelbine-combined therapy for metastatic breast cancer].
    Onishi I; Tsugawa K; Nakamura M; Nishimura G; Fujimura T; Taniya T; Kayahara M; Shimizu K; Ohta T; Miwa K
    Gan To Kagaku Ryoho; 2004 May; 31(5):743-6. PubMed ID: 15170984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of recurrent breast cancer with lung metastasis and overexpression of HER2 that responded to UFT and cyclophosphamide combination therapy after sequential treatments with epirubicin, taxanes, and trastuzumab].
    Nishimura R; Nagao K; Miyayama H; Okazaki S; Nakagawa K; Fujimura Y
    Gan To Kagaku Ryoho; 2003 Jun; 30(6):879-82. PubMed ID: 12852361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful neoadjuvant therapy with trastuzumab, paclitaxel and epirubicin for an elderly patient with inflammatory breast cancer.
    Shimizu T; Hirano A; Watanabe O; Kinoshita J; Kimura K; Kamimura M; Domoto K; Kim N; Ogawa K; Fujibayashi M
    Anticancer Res; 2010 Feb; 30(2):581-5. PubMed ID: 20332474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On and off metronomic oral vinorelbine in elderly women with advanced breast cancer.
    De Iuliis F; Salerno G; Taglieri L; Lanza R; Scarpa S
    Tumori; 2015; 101(1):30-5. PubMed ID: 25702645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer.
    Joensuu H; Kellokumpu-Lehtinen PL; Bono P; Alanko T; Kataja V; Asola R; Utriainen T; Kokko R; Hemminki A; Tarkkanen M; Turpeenniemi-Hujanen T; Jyrkkiö S; Flander M; Helle L; Ingalsuo S; Johansson K; Jääskeläinen AS; Pajunen M; Rauhala M; Kaleva-Kerola J; Salminen T; Leinonen M; Elomaa I; Isola J;
    N Engl J Med; 2006 Feb; 354(8):809-20. PubMed ID: 16495393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of stage IV breast cancer responding to S-1 therapy after FEC and PTX therapies].
    Aoyagi H; Kaneko J; Makinose T; Someno Y; Katsuta E; Saguchi M; Okubo K; Hamada S; Sekine T; Sato T; Sugihara K; Maejima S
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2474-6. PubMed ID: 20037460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic effects of vinorelbine-based chemotherapy--retrospective study of 65 patients with metastatic or relapsed breast cancer].
    Watanabe K; Otake T; Yasuda M; Takenoshita S
    Gan To Kagaku Ryoho; 2010 Jan; 37(1):51-6. PubMed ID: 20087032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of weekly docetaxel, vinorelbine, and trastuzumab in the first-line treatment of patients with HER2-positive metastatic breast cancer.
    Infante JR; Yardley DA; Burris HA; Greco FA; Farley CP; Webb C; Spigel DR; Hainsworth JD
    Clin Breast Cancer; 2009 Feb; 9(1):23-8. PubMed ID: 19299236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of response by breast helical computed tomography to neoadjuvant chemotherapy in large inflammatory breast cancer.
    Moyses B; Haegele P; Rodier JF; Lehmann S; Petit T; Velten M; Schraub S
    Clin Breast Cancer; 2002 Jan; 2(4):304-10. PubMed ID: 11899363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of trastuzumab every 3 weeks combined with cytotoxic chemotherapy in patients with HER2-positive recurrent breast cancer: findings from a case series.
    Ardavanis A; Tryfonopoulos D; Orfanos G; Karamouzis M; Scorilas A; Alexopoulos A; Rigatos G
    Onkologie; 2005 Nov; 28(11):558-64. PubMed ID: 16249641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dramatic response of choroidal metastases from breast cancer to a combination of trastuzumab and vinorelbine.
    Wong ZW; Phillips SJ; Ellis MJ
    Breast J; 2004; 10(1):54-6. PubMed ID: 14717761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.